'If the systolic and diastolic categories are different, follow recommendation for the shorter time follow up (e.g., 160/85 mm Hg should be evaluated or referred to source of care within 1 month.
tThe scheduling of follow up should be modified by reliable information about past blood pressure measurements, other cardiovascular risk factors, or target organ disease.
§Consider providing advice about lifestyle modifications. 
Recommendations for Follow Up Based on Initial
Set of Blood Pressure Measurements for Adults "mild hypertensives" or "moderate hypertensives" are without risk or need for intervention. According to the JNC V Report:
All stages of hypertension are associated with increased risk of nonfatal and fatal cardiovascular disease events and renal disease. The higher the blood pressure, the greater the risk (Joint National Committee, 1993) .
The report recommends that blood pressure measurements be taken on seated clients after 5 minutes of rest, using appropriate cuff size (bladder encircling 80% of the arm) with recently calibrated equipment. Both systolic and diastolic pressures should be recorded using the disappearance of sound (phase V) for the diastolic measurement. Two or more readings separated by 2 minutes should be averaged, and if the first two readings differ by more than 5 mm Hg, additional readings should be taken.
Another useful tool can be found in the report's recommendations for follow up shown in Table 2 . Once hypertension is established, individuals should have a complete clinical evaluation.
The purpose of such an evaluation is to determine if the person has a reversible cause (secondary hyperten- §Based on the average of two or more readings taken at each of two or more visits following an initial screening. Note: In addition to classifying stages of hypertension based on average blood pressure levels, the clinician should specify presence or absence of target organ disease and additional risk factors. For example, a client with diabetes and a blood pressure of 142/94 mmHg plus left ventricular hypertrophy should be classified as "stage 1 hypertension with target organ disease (left ventricular hypertrophy) and with another major risk factor (diabetes) ." This specificity is important for risk classification and management. It is well established that high blood pressure increases with age, is greater in African Americans, and is greater in less educated people. Coronary heart disease, stroke, renal disease, and all cause mortality increase progressively with higher levels of systolic and diastolic blood pressure. Risks are lowest for adults with average blood pressures of less than 120 mm Hg systolic and 80 mm Hg diastolic (Joint National Committee, 1993).
One of the best features of the JNC V Report is the new classification of high blood pressure (Table I) . This new classification is based on risk and seeks to dispel any previous misconceptions that the prior terminology of Health.
Special PopUlations
Certain segments of the population deserve special attention in regard to hypertension. These include Afri-In many cases pharmacologic treatment will be needed even if lifestyle modifications have been successfully adopted. The report points out that diuretics and beta blockers should receive initial consideration as a treatment modality for all stages because they have been shown to reduce cardiovascular morbidity and mortality in controlled clinical trials. Clear guidance is presented on using alternative agents (calcium antagonist, angiotension converting enzyme inhibitors, alpha beta blockers) and on implementing combination therapy in resistant cases. Several comprehensive and useful tables on treatment are presented, including a treatment algorithm shown in the Figure. 1~~~Yf 'i"!.I,,;.,.,';' ,·.~~<.<;.""i .T
ABLE 3
Lifestyle Modification for Hypertension Control and/or Overall Cardiovascular Risk eLose weight if overweight. eLimit alcohol intake to no more than 1 ounce of ethanol per day (24 ounces of beer, 8 ounces of wine, or 2 ounces of 100 proof whiskey). eExercise (aerobics) regularly. eReduce sodium intake to less than 100 mmol per day «2.3 grams of sodium or <6 grams of sodium chloride). eMaintain adequate dietary potassium, calcium, and magnesium intake. eStop smoking and reduce dietary saturated fat and cholesterol intake for overall cardiovascular health. eReducing fat intake also helps reduce calorie intake-important for control of weight and Type II diabetes. sion) for their elevated blood pressure; if any "target organ disease is present (i.e., coronary, cerebrovascular, or renal); and to identify any other cardiovascular risks that may be present in addition to hypertension. A good medical history, physical examination, and selected laboratory studies (urinalysis, complete blood count, blood chemistry including lipid analysis and electrocardiography) should be performed. This evaluation provides answers about reversibility, target organ disease, and other risk factors, along with providing an appropriate baseline for any subsequent treatment (Joint National Committee, 1993) .
7i'eatment
The goal of treating patients with hypertension is to prevent morbidity and mortality associated with high blood pressure and to control blood pressure by the least intrusive means possible (Erfurt, 1990) .
JNC V highlights the fact that lifestyle modifications can be used as a treatment modality for prevention and management of high blood pressure. Lifestyle modifications are effective in lowering the blood pressure of many people who follow them and also can reduce other risk factors for premature cardiovascular disease. In addition, lifestyle modifications offer many benefits at low cost and with minimal risk. Specific lifestyle modifications include weight reduction; increased physical activity; dietary moderation, especially for sodium consumption; and moderation of alcohol consumption (Table 3 ).
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Hypertension continues to be a significant medical and public health concem affecting as many as 50 million Americans.
Early detection, treatment, and control of hypertension is important in reducing coronary heart disease, stroke, and mortality.
Occupational health professionals have a great opportunity to enhance detection, treatment, and control of hypertension through worksite health programs.
The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure's publication, "The Fifth Report of the Joint National Committee," is a valuable resource to occupational health professionals in addressing employee hypertension in the workplace. can Americans, children, women, older clients, and clients with coexisting diseases and unique clinical situations. The JNC V Report recognizes the uniqueness of these population groups as applied to hypertension and makes specific recommendations to address these situations.
JNC V REPORT AND APPLICATION TO OCCUPATIONAL HEALTH
Combating hypertension involves prevention, early detection, and effective treatment that results in blood pressure control. Occupational health care professionals are uniquely positioned to offer interventions in all of these areas. Furthermore, since wellness, health promotion, and disease prevention account for a large portion of the daily work, occupational health providers have even more opportunities to address these issues. Identifying persons with hypertension, counseling, and referrals fit in easily with all components of many occupational health programs.
Barriers to successful treatment as outlined in JNC V have been successfully conquered in workplace wellness programs. A review of workplace hypertension programs found that successful programs provided regular outreach to persons with hypertension, feedback about blood pressure levels, interpretation and reinforcement of prescribed treatment regimens, positive reinforcement for compliance with therapy, and consultation on problems in maintaining treatment (Erfurt, 1990) .
As noted in JNC V, planned client education programs may significantly improve adherence to treatment schedules, improve blood pressure control, and decrease hypertension related morbidity and mortality. Combination strategies achieve the greatest improvement.
SUMMARY
Worksite health programs can provide a significant JUNE 1995, VOL. 43, NO.6 and positive influence on the detection, treatment, and control of hypertension. Using JNC V will enhance and strengthen efforts of occupational health providers to improve detection and effective treatment of hypertension among employees. Copies of the iNC V Report may be obtained from the National High Blood Pressure Education Information Center; 4733 Bethesda Ave, Suite 530, Bethesda, MD 20814-4820, (30/) 251-1222. 
